Investors
Bioluminescence is a leading US biotechnology venture capital firm investing in the future of medicine.
Double Point Ventures is a US-based venture capital fund investing in visionaries shaping the future of healthcare.
Earlybird is a European venture capital investor focused on early-stage companies improving patient outcomes.
Savanne Life Sciences is the investment arm of Bioculture Group focused on investing in emerging biotechnology companies and is based in Mauritius.